Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys
Gregory T. Collins, Lisa R. Gerak, Martin A. Javors, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 356, Iss. 1, pp. 85-95
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The dopamine motive system: implications for drug and food addiction
Nora D. Volkow, Roy A. Wise, Rubén Baler
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 12, pp. 741-752
Closed Access | Times Cited: 812
Improving translation of animal models of addiction and relapse by reverse translation
Marco Vènniro, Matthew L. Banks, Markus Heilig, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 625-643
Closed Access | Times Cited: 181
Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats
Harshini Neelakantan, Erica Holliday, Robert G. Fox, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 5, pp. 1065-1073
Open Access | Times Cited: 91
Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Guy A. Higgins, Paul Fletcher, William Shanahan
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107417-107417
Closed Access | Times Cited: 67
The serotonin 5-HT2Creceptor and the non-addictive nature of classic hallucinogens
Clinton E. Canal, Kevin S. Murnane
Journal of Psychopharmacology (2016) Vol. 31, Iss. 1, pp. 127-143
Open Access | Times Cited: 54
Effects of Lorcaserin on Cocaine and Methamphetamine Self-Administration and Reinstatement of Responding Previously Maintained by Cocaine in Rhesus Monkeys
Lisa R. Gerak, Gregory T. Collins, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2016) Vol. 359, Iss. 3, pp. 383-391
Open Access | Times Cited: 44
Repeated 7-Day Treatment with the 5-HT2C Agonist Lorcaserin or the 5-HT2A Antagonist Pimavanserin Alone or in Combination Fails to Reduce Cocaine vs Food Choice in Male Rhesus Monkeys
Matthew L. Banks, S. Stevens Negus
Neuropsychopharmacology (2016) Vol. 42, Iss. 5, pp. 1082-1092
Open Access | Times Cited: 39
The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study
Jimmie L. Pirtle, Melissa D. Hickman, Varun C. Boinpelly, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 180, pp. 52-59
Open Access | Times Cited: 39
Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia
Tom H. Johnston, Alix M.B. Lacoste, Paula Ravenscroft, et al.
Neuropharmacology (2024) Vol. 248, pp. 109880-109880
Open Access | Times Cited: 4
The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders
Gregory T. Collins, Lisa R. Gerak, Charles P. France
Neuropharmacology (2017) Vol. 142, pp. 63-71
Open Access | Times Cited: 36
Choice between delayed food and immediate opioids in rats: treatment effects and individual differences
Leigh V. Panlilio, Maria E. Secci, Charles W. Schindler, et al.
Psychopharmacology (2017) Vol. 234, Iss. 22, pp. 3361-3373
Open Access | Times Cited: 35
Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
E. Andrew Townsend, S. Stevens Negus, Justin L. Poklis, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107848-107848
Open Access | Times Cited: 30
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder
Laura Brandt, Jermaine D. Jones, Suky Martinez, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107859-107859
Open Access | Times Cited: 29
Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys
David R. Maguire, Lisa R. Gerak, James H. Woods, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 368, Iss. 1, pp. 88-99
Open Access | Times Cited: 32
Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys
Stephen J. Kohut, Jack Bergman
European Journal of Pharmacology (2018) Vol. 840, pp. 28-32
Open Access | Times Cited: 31
Role of impulsivity and reward in the anti-obesity actions of 5-HT2Creceptor agonists
Guy A. Higgins, Fiona D. Zeeb, Paul Fletcher
Journal of Psychopharmacology (2017) Vol. 31, Iss. 11, pp. 1403-1418
Closed Access | Times Cited: 30
Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys.
Lisa R. Gerak, Gregory T. Collins, David R. Maguire, et al.
Experimental and Clinical Psychopharmacology (2018) Vol. 27, Iss. 1, pp. 78-86
Open Access | Times Cited: 28
Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration
Noelle C. Anastasio, Dennis J. Sholler, Robert G. Fox, et al.
Neuropharmacology (2020) Vol. 168, pp. 108009-108009
Open Access | Times Cited: 25
Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.
Gregory T. Collins, Charles P. France
Experimental and Clinical Psychopharmacology (2018) Vol. 26, Iss. 5, pp. 488-496
Open Access | Times Cited: 24
Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
S. Stevens Negus, Matthew L. Banks
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1967-1973
Open Access | Times Cited: 23
Converging vulnerability factors for compulsive food and drug use
Katherine M. Serafine, Laura E. O’Dell, Eric P. Zorrilla
Neuropharmacology (2021) Vol. 196, pp. 108556-108556
Open Access | Times Cited: 19
Confronting the challenge of failed translation in medications development for substance use disorders
S. Stevens Negus, Matthew L. Banks
Pharmacology Biochemistry and Behavior (2021) Vol. 210, pp. 173264-173264
Open Access | Times Cited: 18
Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats
Brenda M. Gannon, Agnieszka Sulima, Kenner C. Rice, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 364, Iss. 2, pp. 359-366
Open Access | Times Cited: 24
Medications for substance use disorders (SUD): emerging approaches
Eduardo R. Butelman, Mary Jeanne Kreek
Expert Opinion on Emerging Drugs (2017) Vol. 22, Iss. 4, pp. 301-315
Open Access | Times Cited: 22
Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
David R. Maguire, Lisa R. Gerak, Jesus J. Sanchez, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1986-1993
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top